Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access Email this article to a friend

Gram-negative antibiotic resistance: there is a price to pay

Thomas G Slama

Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.